16.04.2015 Views

ANNUAL REPORT 2012 - TiGenix

ANNUAL REPORT 2012 - TiGenix

ANNUAL REPORT 2012 - TiGenix

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

5. Information about the<br />

Company and the Group<br />

5.1. GENERAL<br />

5.2. CORPORATE PURPOSE<br />

<strong>TiGenix</strong> was incorporated on February<br />

21, 2000 for an unlimited duration. The<br />

Company has the legal form of a limited<br />

liability company making or having made<br />

a public appeal on savings (naamloze<br />

vennootschap – NV die een openbaar<br />

beroep op het spaarwezen doet of heeft<br />

gedaan / société anonyme – SA faisant<br />

ou ayant fait appel public à l’épargne)<br />

organised and existing under the laws of<br />

Belgium. Pursuant to the Companies Code,<br />

the liability of the shareholders is, in principle,<br />

limited to the amount of their respective<br />

committed contribution to the capital of<br />

the Company. The Company’s registered<br />

office is located at Romeinse straat 12, box<br />

2, 3001 Leuven, Belgium. The Company is<br />

registered with the register of legal entities<br />

(rechtspersonenregister – RPR / registre<br />

des personnes morales - RPM) (Leuven)<br />

under enterprise number 0471.340.123. The<br />

Company can be reached by phone at the<br />

number +32 (0)16 39 60 60.<br />

This chapter summarises the corporate<br />

purpose, share capital and corporate<br />

structure of the Company and is partially<br />

based on the Company’s Articles of<br />

Association that have last been amended<br />

by the meeting of the Board of Directors of<br />

December 27, <strong>2012</strong>.<br />

The corporate purpose of the Company is set<br />

forth in Article 3 of its Articles of Association<br />

and reads as follows :<br />

“The company has as its corporate purpose<br />

engaging in activities in the field of research<br />

and development regarding biological<br />

compounds and biomaterials for its own<br />

account and for the account of third<br />

parties, as well as the industrialisation and<br />

commercialisation of the results hereof.<br />

It may engage in all possible commercial,<br />

industrial, financial, movable and<br />

immovable, transactions, which are, directly<br />

or indirectly related to its corporate purpose<br />

or which are likely to enhance it. It may,<br />

amongst others, cooperate with, participate<br />

in, in any way whatsoever, directly or<br />

indirectly, take a stake in each enterprise<br />

the corporate purpose of which is similar,<br />

analogous or related to its own purpose.<br />

It may mortgage its real estate and may<br />

pledge all its other assets, including its entire<br />

business, and it may guarantee a bill for all<br />

loans, credits and other undertakings, on<br />

its own behalf as well as on behalf of third<br />

parties, provided that the company itself has<br />

an interest thereto.”<br />

The description hereafter is only a summary<br />

and does not purport to give a complete<br />

overview of the Company’s Articles of<br />

Association, nor of all relevant provisions of<br />

Belgian law. Neither should it be considered<br />

as legal advice regarding these matters.<br />

26 <strong>TiGenix</strong> I annual report <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!